Press Releases

Date Title and Summary View
Toggle Summary NxStage Announces Second Quarter 2017 Investor Conference Schedule
LAWRENCE, Mass. , May 25, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, plans to participate in the following schedule of investor conferences.
View HTML
Toggle Summary NxStage Medical Announces FDA Clearance for its New System One Hemodialysis System
LAWRENCE, Mass. , May 10, 2017 /PRNewswire/ --  NxStage Medical, Inc . (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received FDA clearance.  This innovative system consists of new features and
View HTML
Toggle Summary NxStage Reports First Quarter Financial Results
- Revenue Increases to $96.8 million, up 9% from Q1'FY16- Company Reaffirms Total Revenue Guidance and Profitability for 2017- Company Continues to Advance NxGen Hemodialysis System and Innovative Pipeline
View HTML
Toggle Summary NxStage® to Report First Quarter 2017 Financial Results
LAWRENCE, Mass. , April 6, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the first quarter ended March 31, 2017 , on Tuesday, May 9, 2017 , before the
View HTML
Toggle Summary New Data Shows Significant Potential Cost Savings with On-Site Hemodialysis in Skilled Nursing Facilities
On-site hemodialysis with NxStage System One provides cost-effective alternative to expensive transportation services associated with off-site dialysis
View HTML
Toggle Summary NxStage Medical Announces CE Mark for its NxGen Hemodialysis System
LAWRENCE, Mass. , March 2, 2017 /PRNewswire/ --  NxStage Medical, Inc . (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received CE Mark approval.  This innovative system consists of new features
View HTML
Toggle Summary NxStage Reports Fourth Quarter and Full-Year 2016 Financial Results
LAWRENCE, Mass. , Feb. 28, 2017 /PRNewswire/ -- Highlights: Full-Year Revenue Increases to $366 million , up 9% from 2015 Full-Year Home Revenue Increases to $209 million , up over 14% from 2015 Full-Year Operating Income from Products Business More than Doubles to $23 million Outlook for 2017
View HTML
Toggle Summary NxStage Announces First Quarter 2017 Investor Conference Schedule
LAWRENCE, Mass. , Feb. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that Jeffrey H. Burbank , Founder and Chief Executive Officer, plans to participate in the following schedule of investor
View HTML
Toggle Summary NxStage Announces Appointment of Chief Medical Officer
Allan J. Collins, M.D., FACP, expands Medical Affairs leadership role within NxStage
View HTML
Toggle Summary NxStage® to Report Fourth Quarter and Full Year 2016 Financial Results
LAWRENCE, Mass. , Jan. 16, 2017 /PRNewswire/ -- NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2016 , on Tuesday, February
View HTML